FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Coronary, Atherectomy

PMA: P900056 · Supplement: S224 · Decision Apr 9, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P900056 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Catheter, Coronary, Atherectomy
Trade Name
Rotablator™; ROTAPRO™ Rotational Atherectomy Systems
PMA Number
P900056
Supplement Number
S224
Device Class
FDA Class 3
Product Code
MCX
Generic Name
CATHETER, CORONARY, ATHERECTOMY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 9, 2026
Date Received
March 12, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

transfer of manufacturing activities of the ROTAWIRE Drive guidewire and wireClip Torquer guidewire manipulation devices from the BSC Heredia, Costa Rica facility to the BSC Coyol, Costa Rica facility

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MCX Catheter, Coronary, Atherectomy